DMEK outcome after one year - Results from a large multicenter study in Germany.


Journal

Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102

Informations de publication

Date de publication:
Mar 2023
Historique:
revised: 08 06 2022
received: 29 06 2021
accepted: 03 09 2022
pubmed: 1 10 2022
medline: 18 2 2023
entrez: 30 9 2022
Statut: ppublish

Résumé

Descemet membrane endothelial keratoplasty (DMEK) accounts for >50% of all corneal transplants in Germany. So far, no data from such a large multicenter study have been published. This retrospective study included 3200 DMEKs at seven departments performed for Fuchs endothelial corneal dystrophy (FECD) or bullous keratopathy (BK). We evaluated best corrected visual acuity (BCVA, logMAR), endothelial cell density (ECD, cells/mm For patients without vision-limiting comorbidities (74% of all analysed eyes, n = 2270), mean BCVA improved from 0.6 ± 0.4 logMAR to 0.2 ± 0.2 logMAR 6 months (p < 0.001, n = 1441) and 0.1 ± 0.2 logMAR 12 months (p = 0.001, n = 1402) postoperatively. BK- had a worse BCVA compared to FECD-patients (0.3 ± 0.5 vs. 0.1 ± 0.2 logMAR [p < 0.001] at 1 year). ECD declined from 2465 ± 259 cells/mm Descemet membrane endothelial keratoplasty increases visual acuity with low transplant failure- and rejection-rates. FECD has a better outcome than BK. Since a quarter of all patients need a rebubbling, this should be included in the informed consent. Remarkably, one rebubbling has no influence on the outcome.

Identifiants

pubmed: 36178238
doi: 10.1111/aos.15257
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e215-e225

Informations de copyright

© 2022 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.

Références

Agha, B., Forster, R., Kohnen, T. & Schmack, I. (2021) Influence of rebubbling on anterior segment parameters and refractive outcomes in eyes with DMEK for Fuchs endothelial dystrophy. Graefe's Archive for Clinical and Experimental Ophthalmology, 259, 3175-3183.
Chamberlain, W., Lin, C.C., Austin, A., Schubach, N., Clover, J., SD, M.L. et al. (2019) Descemet endothelial thickness comparison trial: A randomized trial comparing ultrathin descemet stripping automated endothelial keratoplasty with descemet membrane endothelial keratoplasty. Ophthalmology, 126, 19-26.
Deng, S.X., Lee, W.B., Hammersmith, K.M., Kuo, A.N., Li, J.Y., Shen, J.F. et al. (2018) Descemet membrane endothelial keratoplasty: Safety and outcomes: A report by the American Academy of Ophthalmology. Ophthalmology, 125, 295-310.
Dirisamer, M., van Dijk, K., Dapena, I., Ham, L., Oganes, O., Frank, L.E. et al. (2012) Prevention and management of graft detachment in descemet membrane endothelial keratoplasty. Archives of Ophthalmology, 130, 280-291.
Donner, A., Birkett, N. & Buck, C. (1981) Randomization by cluster. Sample size requirements and analysis. American Journal of Epidemiology, 114, 906-914.
Dunker, S.L., Veldman, M.H.J., Winkens, B., van den Biggelaar, F.J.H.M., Nuijts, R.M.M.A., Kruit, P.J. et al. (2021) Real-World Outcomes of DMEK: A Prospective Dutch registry study. American Journal of Ophthalmology, 222, 218-225.
Eye Bank Association of America. (2021) EBAO 2020 eye banking statistical report. Personal communication 23rd September 2021.
Feng, M.T., Price, M.O., Miller, J.M. & Price, F.W.J. (2014) Air reinjection and endothelial cell density in Descemet membrane endothelial keratoplasty: Five-year follow-up. Journal of Cataract and Refractive Surgery, 40, 1116-1121.
Flockerzi, E., Maier, P., Böhringer, D., Reinshagen, H., Kruse, F. & Cursiefen, C. . (2018) Trends in corneal transplantation from 2001 to 2016 in Germany: A report of the DOG-section cornea and its keratoplasty registry. American Journal of Ophthalmology, 188, 91-98.all GKRC
Gerber-Hollbach, N., Baydoun, L., López, E.F., Frank, L.E., Dapena, I., Liarakos, V.S. et al. (2017) Clinical outcome of rebubbling for graft detachment after descemet membrane endothelial keratoplasty. Cornea, 36, 771-776.
Guerra, F.P., Anshu, A., Price, M.O., Giebel, A.W. & Price, F.W. (2011) Descemet's membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology, 118, 2368-2373.
Gundlach, E., Pilger, D., Dietrich-Ntoukas, T., Joussen, A.M., Torun, N. & Maier, A.B. (2020) Impact of Re-bubbling after descemet membrane endothelial keratoplasty on long-term results. Current Eye Research, 46, 1-5.
Hayashi, T., Schrittenlocher, S., Siebelmann, S., Le, V.N.H., Matthaei, M., Franklin, J. et al. (2020) Risk factors for endothelial cell loss after Descemet membrane endothelial keratoplasty (DMEK). Scientific Reports, 10, 11086.
Heinzelmann, S., Böhringer, D., Eberwein, P., Reinhard, T. & Maier, P. (2016) Outcomes of Descemet membrane endothelial keratoplasty, Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty from a single centre study. Graefe's Archive for Clinical and Experimental Ophthalmology, 254, 515-522.
Kruse, F.E., Laaser, K., Cursiefen, C., Heindl, L.M., Schlotzer-Schrehardt, U., Riss, S. et al. (2011) A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet membrane endothelial keratoplasty. Cornea, 30, 580-587.
Livny, E., Groeneveld-van Beek, E.A., Lie, J.T., Mangundap, K.M., Bruinsma, M., Birbal, R.S. et al. (2017) Minimizing graft preparation failure in descemet membrane endothelial keratoplasty. Cornea, 36, 1452-1457.
Matsou, A., Pujari, R., Sarwar, H., Rana, M., Myerscough, J., Thomson, S.M. et al. (2021) Microthin descemet stripping automated endothelial keratoplasty versus descemet membrane endothelial keratoplasty: A randomized clinical trial. Cornea, 40, 1117-1125.
Melles, G.R. (2006) Posterior lamellar keratoplasty: DLEK to DSEK to DMEK. Cornea, 25, 879-881.
Oellerich, S., Baydoun, L., Peraza-Nieves, J., Ilyas, A., Frank, L., Binder, P.S. et al. (2017) Multicenter study of 6-month clinical outcomes after descemet membrane endothelial keratoplasty. Cornea, 36, 1467-1476.
Peraza-Nieves, J., Baydoun, L., Dapena, I., Ilyas, A., Frank, L.E., Luceri, S. et al. (2017) Two-year clinical outcome of 500 consecutive cases undergoing descemet membrane endothelial keratoplasty. Cornea, 36, 655-660.
Phillips, P.M., Phillips, L.J., Muthappan, V., Maloney, C.M. & Carver, C.N. (2017) Experienced DSAEK surgeon's transition to DMEK: outcomes comparing the last 100 DSAEK surgeries with the first 100 DMEK surgeries exclusively using previously published techniques. Cornea, 36, 275-279.
Price, M.O., Gupta, P., Lass, J. & Price, F.W. (2017) EK (DLEK, DSEK, DMEK): New Frontier in Cornea Surgery. Annu Rev Vis Sci, 3, 69-90.
Price, M.O. & Price, F.W.J. (2010) Endothelial keratoplasty - a review. Clinical & Experimental Ophthalmology, 38, 128-140.
Schaub, F., Bachmann, B.O., Cursiefen, C. & Hos, D. (2019) Midterm follow-up of immune reactions after Descemet membrane endothelial keratoplasty (DMEK).[letter]. Graefe's Archive for Clinical and Experimental Ophthalmology, 257(8), 1811-1812.
Schrittenlocher, S., Bachmann, B., Tiurbe, A.M., Tuac, O., Velten, K., Schmidt, D. et al. (2019) Impact of preoperative visual acuity on descemet membrane endothelial keratoplasty (DMEK) outcome. Graefe's Archive for Clinical and Experimental Ophthalmology, 257, 321-329.
Schrittenlocher, S., Schaub, F., Hos, D., Siebelmann, S., Cursiefen, C. & Bachmann, B. (2018) Evolution of consecutive descemet membrane endothelial keratoplasty outcomes throughout a 5-year period performed by two experienced surgeons. American Journal of Ophthalmology, 190, 171-178.
Seitz, B., Daas, L., Flockerzi, E. & Suffo, S. (2020) Descemet membrane endothelial keratoplasty DMEK - Donor and recipient step by step. Der Ophthalmologe, 117, 811-828.
Spaniol, K., Holtmann, C., Schwinde, J.H., Deffaa, S., Guthoff, R. & Geerling, G. (2016) Descemet-membrane endothelial keratoplasty in patients with retinal comorbidity-a prospective cohort study. International Journal of Ophthalmology, 9, 390-394.
Tourtas, T., Laaser, K., Bachmann, B.O., Cursiefen, C. & Kruse, F.E. (2012) Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. American Journal of Ophthalmology, 153, 1082-90.e2.
Vasiliauskaitė, I., Quilendrino, R., Baydoun, L., van Dijk, K., Melles, G.R.J. & Oellerich, S. (2021) Effect of six-month postoperative endothelial cell density on graft survival after descemet membrane endothelial keratoplasty. Ophthalmology, 128, 1689-1698.

Auteurs

Kristina Spaniol (K)

Department of Ophthalmology, University Hospital Düsseldorf, Düsseldorf, Germany.

Martin Hellmich (M)

Institute of Medical Statistics and Computational Biology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Klara Borgardts (K)

Department of Ophthalmology, University Hospital Düsseldorf, Düsseldorf, Germany.

Christian Girbardt (C)

Department of Ophthalmology, University Hospital Leipzig, Leipzig, Germany.

Philip Maier (P)

Eye Center, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Thomas Reinhard (T)

Eye Center, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Necip Torun (N)

Department of Ophthalmology, Charité Universitätsmedizin - Berlin, Corporate Member of Freie Universität Berlin, Humbolt-Universität zu Berlin und Berlin Institute of Health, Berlin, Germany.

Anna-Karina Maier (AK)

Department of Ophthalmology, Charité Universitätsmedizin - Berlin, Corporate Member of Freie Universität Berlin, Humbolt-Universität zu Berlin und Berlin Institute of Health, Berlin, Germany.

Sebastian Thaler (S)

Department of Ophthalmology, University Hospital Tübingen, Tübingen, Germany.

Karl U Bartz-Schmidt (KU)

Department of Ophthalmology, University Hospital Tübingen, Tübingen, Germany.

Peter Wiedemann (P)

Department of Ophthalmology, University Hospital Leipzig, Leipzig, Germany.

Berthold Seitz (B)

Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany.

Loay Daas (L)

Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany.

Silvia Schrittenlocher (S)

Department of Ophthalmology, University Hospital Cologne, Cologne, Germany.

Claus Cursiefen (C)

Department of Ophthalmology, University Hospital Cologne, Cologne, Germany.

Björn Bachmann (B)

Department of Ophthalmology, University Hospital Cologne, Cologne, Germany.

Gerd Geerling (G)

Department of Ophthalmology, University Hospital Düsseldorf, Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH